Difference between revisions of "Part:BBa K1980000"

(References)
 
(7 intermediate revisions by the same user not shown)
Line 2: Line 2:
 
__NOTOC__
 
__NOTOC__
 
<partinfo>BBa_K1980000 short</partinfo>
 
<partinfo>BBa_K1980000 short</partinfo>
 +
==Description==
 
<p>
 
<p>
 
Copper Storage protein 1 (Csp1) is a tetrameric copper storage protein found in the periplasm of Methylosinus trichosporium OB3b. We investigated whether this part could act as a copper chelator when expressed in E. coli.  
 
Copper Storage protein 1 (Csp1) is a tetrameric copper storage protein found in the periplasm of Methylosinus trichosporium OB3b. We investigated whether this part could act as a copper chelator when expressed in E. coli.  
Line 19: Line 20:
 
<li>As <i> E. coli </i>naturally deals with copper toxicity by binding copper in the periplasm then exporting it, periplasmic proteins may reduce toxicity to the host. </li>
 
<li>As <i> E. coli </i>naturally deals with copper toxicity by binding copper in the periplasm then exporting it, periplasmic proteins may reduce toxicity to the host. </li>
 
</ul>
 
</ul>
<p>Copper storage protein 1 is a protein discovered in a methane-oxidizing alphaproteobacterium called <i>Methylosinus trichosporium OB3b. </i> (OB3b here stands for “oddball” strain 3b). This bacterium has a high demand for copper for use in its particular methane monoxygenase enzyme. Vita et al. <sup>(1)</sup> discovered Csp1 in 2015, characterised the protein’s copper affinity and obtained crystal structures with and without copper.
+
<p>Copper storage protein 1 is a protein discovered in a methane-oxidizing alphaproteobacterium called <i>Methylosinus trichosporium OB3b. </i> (OB3b here stands for “oddball” strain 3b). This bacterium has a high demand for copper for use in its particular methane monoxygenase enzyme. Vita et al.<sup>(1)</sup> discovered Csp1 in 2015, characterised the protein’s copper affinity and obtained crystal structures with and without copper.
 
</p>
 
</p>
 
<p>
 
<p>
Line 31: Line 32:
 
We codon optimised Csp1 to <i>E. coli</i> and replaced the original TAT sequence with a TAT sequence from the <i>E. coli</i> protein CueO, which is also involved in copper regulation. To get Csp1 from the shipping vector to the pBAD expression system for testing the TAT sequence had to be modified by the addition of a serine residue after the initiator methionine. Serine was chosen over other amino acid possibilities because other TAT sequences seemed to have serine in this location.  
 
We codon optimised Csp1 to <i>E. coli</i> and replaced the original TAT sequence with a TAT sequence from the <i>E. coli</i> protein CueO, which is also involved in copper regulation. To get Csp1 from the shipping vector to the pBAD expression system for testing the TAT sequence had to be modified by the addition of a serine residue after the initiator methionine. Serine was chosen over other amino acid possibilities because other TAT sequences seemed to have serine in this location.  
 
</p>
 
</p>
[[Image:T--Oxford--Sam-csp1-mono.jpg|600px|thumb|centre|'''Figure 1:''' A Csp1 monomer]]
+
[[Image:T--Oxford--Sam-csp1-mono.jpg|400px|thumb|centre|'''Figure 1:''' A Csp1 monomer]]
  
 
==Experience==
 
==Experience==
 
<p> We cloned Csp1 from Gblock into the shipping vector then transferred it into the pBAD, arabinose-inducible commercial expression vector. This transfer necessitated the changing of the TAT sequence by the addition of a serine residue after the initiator methionine</p>
 
<p> We cloned Csp1 from Gblock into the shipping vector then transferred it into the pBAD, arabinose-inducible commercial expression vector. This transfer necessitated the changing of the TAT sequence by the addition of a serine residue after the initiator methionine</p>
+
 
<p>We were unable however to detect copper chelation activity of Csp1 when expressed from pBAD in MG1655 <i>E. coli</i> strain, using a BCS absorbance assay. Modelling by our team suggested that this was because insufficient protein could be expressed to chelate the amount needed to be detectable on the assay. ( 2 μM detection limit)</p>
+
===Absorbance Assay===
<p>We purified this a version of this part with a C-terminal His tagged-sfGFP (BBa K1980001),  but were still unable to detect copper chelation with the assay in our purified extracts.</p>
+
<html>
 +
<p>We were unable however to detect copper chelation activity of Csp1 when expressed from pBAD in MG1655 <i>E. coli</i> strain, using an absorbance assay.
 +
</p>
 +
<p>
 +
The assay used was the reagent Bathocuproine disulphonic Acid (BCS). BCS is colourless in the absence of Cu<sup>+</sup> but upon exposure to Cu<sup>+</sup>, BCS forms complexes with Cu<sup>+</sup> and absorbs strongly in the 480nm range. In our assays, at concentrations of 50µg/mL, the 480nm absorbance varied linearly with the Cu+ concentration from the detection limit of around 1µM Cu<sup>+</sup>, to approximately 20µM Cu<sup>+</sup>. As not only MymT and Csp1 bind copper in the Cu<sup>+</sup> form, but the assay also requires singly charged copper, the assays were optimised to include a suitable about of mild reducing agent to ensure reduction of the added CuSO<sub>4</sub> (releases Cu<sup>2+</sup>) to Cu<sup>+</sup>. After trying L(+)-Ascorbate and DL-Dithiothreitol, and L-Glutathione as candidates, L-Glutathione was selected as it was both mild enough to not damage biological material and efficient at reducing Cu<sup>2+</sup>. At >2-3 times the concentration of Cu<sup>2+</sup> in solution, L-Glutathione had maximum reductive activity against Cu<sup>2+</sup>.</p>
 +
<p> Modelling by our team suggested that this was because insufficient protein could be expressed to chelate the amount needed to be detectable on the assay (1μM detection limit).</p>
 +
<p>We purified this a version of this part with a C-terminal His tagged-sfGFP (<a href="https://parts.igem.org/Part:BBa_K1980001">BBa K198001</a>),  but were still unable to detect copper chelation with the assay in our purified extracts.</p>
  
 
<p>   
 
<p>   
When expressed from the pBAD, arabinose-inducible commercial expression plasmid, or from our copper sensitive promoter (part BBa_K1980010) our version of Csp1sfGFP (BBa_K1980001) was observed to form inclusion bodies in the cytoplasm:</p>
+
When expressed from the pBAD, arabinose-inducible commercial expression plasmid, or from our copper sensitive promoter (<a href="https://parts.igem.org/Part:BBa_K1980010">BBa K1980010</a>) our version of Csp1sfGFP (<a href="https://parts.igem.org/Part:BBa_K1980001">BBa K1980001</a>) was observed to form inclusion bodies in the cytoplasm and not be expressed as a periplasmic protein as we had hoped:</p></html>
 
[[Image:BBa K1980000 cg microscopy.jpeg|600px|thumb|centre|'''Figure 1:''' Csp1sfGFP in the pBAD system with 2mM arabinose]]
 
[[Image:BBa K1980000 cg microscopy.jpeg|600px|thumb|centre|'''Figure 1:''' Csp1sfGFP in the pBAD system with 2mM arabinose]]
===FLIM===
 
<p>
 
We discovered a speculative paper by Hotzer et al<sup>(2)</sup> that described how His-tagged GFP can be quenched by a copper ion binding to this His tag leading to a reduction in the fluorescence lifetime (the time the fluorophore spends in the excited state before returning to the ground state by emitting a photon.) They speculated that this could potentially be used as a <i>in vivo</i> copper assay.
 
</p>
 
https://static.igem.org/mediawiki/2016/3/32/FLIM_diagram_sam_oxford_2016.png
 
<p>
 
(2) Hötzer B., Ivanov R., Altmeier S., Kappl R., Jung G., (2011) "Determination of copper(II) ion concentration by lifetime measurements of green fluorescent protein."  Journal of Fluorescence, 21(6), pp. 2143-2153. doi: 10.1007/s10895-011-0916-1
 
</p>
 
<p>
 
As we had His-tagged our chelator-sfGFP constructs we were curious to see if this technique could be applied to our parts to measure copper chelation in vivo by our parts. We believe that two possibilities were likely:
 
</p>
 
<ol>
 
<li>Copper chelation by the chelator reduces the free copper concentration inside the cell meaning that less binds to the His tag and the fluorescence lifetime will be greater than a His-tagged sfGFP control</li>
 
<li>Copper chelation by the chelator would allow additional quenching if copper was bound within the quenching radius of the fluorophore leading to a reduction in fluorescence lifetime compare with a sfGFP control</li>
 
</ol>
 
<p>
 
Lacking access to a fluorescence lifetime microscope ourselves we contacted Cardiff iGEM who had a FLIM machine in their bioimaging unit. They very kindly agreed to run a few samples for us taking up over five hours of microscope time.
 
</p>
 
<p>
 
We sent Cardiff iGEM our parts Csp1-sfGFP in pBAD and pCopA CueR sfGFP (as a control) in live MG1655 <i>E. coli</i> in agar tubes. Cardiff grew them overnight in 5ml of LB with 5uM copper with and without 2mM arabinose.
 
</p>
 
<p>
 
The imaging unit spread each strain on slides and measured the fluorescence lifetime of three areas on each slide.</p>
 
<p> (Acquisition parameters: using the x63 water immersion objective with excitation at 483nm (71% intensity, pulse rate 40MHz) and emission via a BP500-550 filter. Scan resolution at 512 x 512 pixels at pixel size of 0.26 microns/pixel, 1AU pinhole.  Counts of >1000 per lifetime recording.)
 
</p>
 
<p>FLIM images from one section of each slide:</p>
 
https://static.igem.org/mediawiki/2016/5/5d/FLIM_images_sam_oxford_2016.png
 
<p>
 
As expected the pCopA CueR sfGFP control was fluorescent, with and without arabinose, with the mean fluorescence lifetime a consistent 2.6ns. </p>
 
<p>
 
When Csp1-sfGFP was induced the mean lifetime decreased to 2.5ns and the variance was increased. This might be indicate that copper chelation has occurred or may be reflective of the expression problems of Csp1.</p>
 
[[Image:T--Oxford--Sam-FLIM-sfGFP.jpg|400px|thumb|left|Histogram showing the fluorescence lifetime of sfGFP at 5uM copper]]
 
[[Image:T--Oxford--Sam-FLIM-Csp1sfGFP.jpg|400px|thumb|right|Histogram showing the fluorescence lifetime of Csp1sfGFP at 5uM copper]]
 
  
 
+
==References==
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
===References===
+
 
<p>(1) Nicolas Vita, Semeli Platsaki, Arnaud Basle, Stephen J. Allen, Neil G. Paterson, Andrew T. Crombie, J. Colin Murrell, Kevin J.Waldron & Christopher Dennison (2015)
 
<p>(1) Nicolas Vita, Semeli Platsaki, Arnaud Basle, Stephen J. Allen, Neil G. Paterson, Andrew T. Crombie, J. Colin Murrell, Kevin J.Waldron & Christopher Dennison (2015)
 
“A four-helix bundle stores copper for methane oxidation”, Nature 525 issue 7567 pg. 140-143 doi:10.1038/nature14854</p>
 
“A four-helix bundle stores copper for methane oxidation”, Nature 525 issue 7567 pg. 140-143 doi:10.1038/nature14854</p>
  
<p>
 
(2) Hötzer B., Ivanov R., Altmeier S., Kappl R., Jung G., (2011) "Determination of copper(II) ion concentration by lifetime measurements of green fluorescent protein."  Journal of Fluorescence, 21(6), pp. 2143-2153. doi: 10.1007/s10895-011-0916-1
 
</p>
 
  
<p style="text-align: right"><i>Author: Sam Garforth and Andreas Hadjicharalambous</i></p>
+
 
 +
<p style="text-align: right"><i>Authors: Sam Garforth and Andreas Hadjicharalambous</i></p>
  
 
<!-- Uncomment this to enable Functional Parameter display  
 
<!-- Uncomment this to enable Functional Parameter display  

Latest revision as of 21:18, 24 October 2016


TAT Copper Storage Protein 1

Description

Copper Storage protein 1 (Csp1) is a tetrameric copper storage protein found in the periplasm of Methylosinus trichosporium OB3b. We investigated whether this part could act as a copper chelator when expressed in E. coli. We modified the protein by adding a TAT signal peptide from the E. coli enzyme CueO in place of the native TAT sequence and added a C terminal his tag to aid purification.


Sequence and Features:


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

Usage and Biology

Our project aimed to detect and chelate dietary copper as a treatment for Wilson's Disease, a copper accumulation disorder. We decided that the ideal copper chelation protein would have these properties:

  • Should be able to bind multiple copper ions per peptide to increase the efficient use of cell resources.
  • They should be from the prokaryotic domain because eukaryotic proteins can have expression issues in Escherichia coli.
  • As E. coli naturally deals with copper toxicity by binding copper in the periplasm then exporting it, periplasmic proteins may reduce toxicity to the host.

Copper storage protein 1 is a protein discovered in a methane-oxidizing alphaproteobacterium called Methylosinus trichosporium OB3b. (OB3b here stands for “oddball” strain 3b). This bacterium has a high demand for copper for use in its particular methane monoxygenase enzyme. Vita et al.(1) discovered Csp1 in 2015, characterised the protein’s copper affinity and obtained crystal structures with and without copper.

Csp1 is a tetramer of four-helix bundles. Each monomer can bind up to 13 Cu(I) ions meaning that the tetramer binds a maximum of 52 copper ions. Vita et al crystallised Csp1 with and without copper bound. The copper is bound inside the pre-folded helical bundles by Cys residues in contrast to metallothioneins, which are unstructured until they fold around metal ion clusters. Vita et al. found an average copper affinity of approximately 1x1017M-1.

Csp1 has a signal peptide targeting it to the twin arginine translocation pathway (TAT). This means that it is likely a periplasmic protein. However they also found cytoplasmic homologues in many species challenging their and our assumption that only copper storage occurs in the periplasm due to copper toxicity.

We codon optimised Csp1 to E. coli and replaced the original TAT sequence with a TAT sequence from the E. coli protein CueO, which is also involved in copper regulation. To get Csp1 from the shipping vector to the pBAD expression system for testing the TAT sequence had to be modified by the addition of a serine residue after the initiator methionine. Serine was chosen over other amino acid possibilities because other TAT sequences seemed to have serine in this location.

Figure 1: A Csp1 monomer

Experience

We cloned Csp1 from Gblock into the shipping vector then transferred it into the pBAD, arabinose-inducible commercial expression vector. This transfer necessitated the changing of the TAT sequence by the addition of a serine residue after the initiator methionine

Absorbance Assay

We were unable however to detect copper chelation activity of Csp1 when expressed from pBAD in MG1655 E. coli strain, using an absorbance assay.

The assay used was the reagent Bathocuproine disulphonic Acid (BCS). BCS is colourless in the absence of Cu+ but upon exposure to Cu+, BCS forms complexes with Cu+ and absorbs strongly in the 480nm range. In our assays, at concentrations of 50µg/mL, the 480nm absorbance varied linearly with the Cu+ concentration from the detection limit of around 1µM Cu+, to approximately 20µM Cu+. As not only MymT and Csp1 bind copper in the Cu+ form, but the assay also requires singly charged copper, the assays were optimised to include a suitable about of mild reducing agent to ensure reduction of the added CuSO4 (releases Cu2+) to Cu+. After trying L(+)-Ascorbate and DL-Dithiothreitol, and L-Glutathione as candidates, L-Glutathione was selected as it was both mild enough to not damage biological material and efficient at reducing Cu2+. At >2-3 times the concentration of Cu2+ in solution, L-Glutathione had maximum reductive activity against Cu2+.

Modelling by our team suggested that this was because insufficient protein could be expressed to chelate the amount needed to be detectable on the assay (1μM detection limit).

We purified this a version of this part with a C-terminal His tagged-sfGFP (BBa K198001), but were still unable to detect copper chelation with the assay in our purified extracts.

When expressed from the pBAD, arabinose-inducible commercial expression plasmid, or from our copper sensitive promoter (BBa K1980010) our version of Csp1sfGFP (BBa K1980001) was observed to form inclusion bodies in the cytoplasm and not be expressed as a periplasmic protein as we had hoped:

Figure 1: Csp1sfGFP in the pBAD system with 2mM arabinose

References

(1) Nicolas Vita, Semeli Platsaki, Arnaud Basle, Stephen J. Allen, Neil G. Paterson, Andrew T. Crombie, J. Colin Murrell, Kevin J.Waldron & Christopher Dennison (2015) “A four-helix bundle stores copper for methane oxidation”, Nature 525 issue 7567 pg. 140-143 doi:10.1038/nature14854


Authors: Sam Garforth and Andreas Hadjicharalambous